Xeris Biopharma Holdings Inc (XERS)

Cash & Short-Term Investments

$121.75M

Quarterly · Period ending: · USD

XERS logo

XERS Cash & Short-Term Investments

Latest reported$121.75M
XERS Quarterly Cash & Short-Term Investments ($32.27M → $121.75M)
High-resolution chart · PNG

XERS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
121,747,000
111,750,000
111,042,000
91,598,000
59,285,000
58,440,000
71,621,000
69,402,000
77,568,000
87,352,000
72,451,000
65,975,000
80,668,000
95,102,000
121,966,000
93,433,000
111,553,000
132,148,000
102,433,000
92,983,000
115,980,000
135,894,000
133,788,000
141,743,000
143,995,000
96,942,000
75,549,000
102,471,000
124,510,000
147,671,000
112,633,000
131,041,000
134,528,000
58,110,000
42,045,000
32,269,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.